1.19 USD
↗ 0.04 (3.48%)AT CLOSE (11:59 AM EDT)
Exicure, Inc. Common Stock
XCURNASDAQ • USD
1.21
↗ 0.02 (1.26%)
POST MARKET (AS OF 07:22 PM EDT)
Post Market
AS OF 07:22 PM EDT
1.21
↗ 0.02 (1.26%)
Market: OPEN
Exicure, Inc. Common Stock (XCUR) is currently trading at $1.21. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, XCUR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 25, 2026.
Open?$1.15
High?$1.23
Low?$1.13
Prev. Close?$1.15
Volume?19.2K
Avg. Volume?807.8K
VWAP?$1.19
Rel. Volume?0.02x
Bid / Ask
Bid?$0.98 × 100
Ask?$1.54 × 100
Spread?$0.56
Midpoint?$1.26
Valuation & Ratios
Market Cap?7.5M
Shares Out?6.5M
Float?4.3M
Float %?67.2%
P/E Ratio?N/A
P/B Ratio?7.71
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Themes
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Phone: 847-673-1707
CHICAGO, IL 60614
Phone: 847-673-1707
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-25.59Distress
Confidence?43%Low
Short InterestLow
Short % of Float?1.41%Low
Short Interest?60.4K
Days to Cover?1.4
Free Float4.3M
Avg Daily Volume43.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?0.56Weak
Quick Ratio?0.56Weak
Cash Ratio?0.41Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?7.71FAIR▾
Peers100
S&P24
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-847.9%WEAK▾
S&P3
ROA?-72.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-7023000
Enterprise Value?$5.8M
Fundamentals ratios updated end of day